Signed in · PRO
Medtronic / Full history

Guidance history, every release

Medtronic (MDT) · 8 releases, Nov 19, 2024 to Sep 1, 2026 · rows are metrics, columns are releases
Raised · a change from the previous releaseSame · restated unchanged— · not stated in that releaseEvery value links to its sentence in the filing
MetricNov 19, 2024
FY25 Q2
Feb 18, 2025
FY25 Q3
May 21, 2025
FY25 Q4
Aug 18, 2025
FY26 Q1
Nov 18, 2025
FY26 Q2
Feb 17, 2026
FY26 Q3
Jun 3, 2026
FY26 Q4
Sep 1, 2026
FY27 Q1
For FY2027
FY27 organic revenue growth——————New“6.75% to 7.25%”Raised“7.25% to 7.75%”
FY27 diluted non-GAAP EPS——————New“$5.90 to $6.00”Narrowed“$5.94 to $6.00”
Annual dividend——————New“$2.88 per share”—
Dividend——————New“$0.72 per share”—
Foreign currency exchange impact included in FY27———————New“neutral to 1% accretive”
Quarterly cash dividend——————New“$0.72 per ordinary share”—
For FY2026
FY26 organic revenue growth——New“approximately 5%”Reiterated“approximately 5%”Raised“approximately 5.5%”Reiterated“approximately 5.5%”——
FY26 revenue growth on a reported basis (including Other revenue and FX impact)———New“6.5% to 6.8%”————
Revenue growth, reported basis (including Other revenue and FX impact, if recent rates hold)——New“4.8% to 5.1%”—————
FY26 diluted non-GAAP EPS———New“$5.60 to $5.66”Narrowed“$5.62 to $5.66”Reiterated“$5.62 to $5.66”——
FY26 diluted non-GAAP EPS (including potential tariff impact)——New“$5.50 to $5.60”—————
FY26 diluted non-GAAP EPS growth, excluding potential impact from tariffs————New“approximately 4.5%”Reiterated“approximately 4.5%”——
FY26 underlying diluted non-GAAP EPS growth (excluding potential tariff impact)———New“approximately 4.5%”————
Annual dividend——————New“$2.88 per ordinary share”—
Potential impact from tariffs————New“approximately $185 million”———
Potential impact from tariffs (included in)—————New“approximately $185 million”——
Quarterly cash dividend——New“$0.71 per ordinary share”—————
For FY2025
FY25 organic revenue growthNew“4.75% to 5%”Reiterated“4.75% to 5%”——————
FY25 revenue growth (including Other revenue and FX impact, if recent rates hold)New“3.4% to 3.9%”———————
FY25 revenue growth (including Other revenue and impact of foreign currency exchange, if recent rates hold)—New“3.4% to 3.8%”——————
Adjusted EPS growthNew“high-single digit”———————
Adjusted EPS growth in the back half of the fiscal year—New“high-single digit”——————
Estimated impact from foreign currency exchange on FY25 diluted non-GAAP EPSNew“-5%”Reiterated“-5%”——————
FY25 diluted non-GAAP EPSNew“$5.44 to $5.50”Reiterated“$5.44 to $5.50”——————
Annual dividend——New“$2.84 per ordinary share”—————
No period stated
Long-term organic revenue growth commitmentNew“mid-single digit”———————
Values in quotation marks are the company’s words. Change labels compare each statement with the same metric and target year in the previous release. HighGravityData does not judge whether guidance was met.